Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
of the following subjects: scalable data management, systems for machine learning, distributed and parallel systems, or cloud-based systems. We are especially interested in researchers who build working systems and
-
of the University of Colorado Anschutz Medical Campus. The Department has grown substantially in the past 15 years, from 40 to 120 faculty in parallel with the remarkable growth of our hospital based affiliates as
-
PhD Positions Application Deadline 31 May 2026 - 12:00 (Europe/Paris) Country France Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 9 Sep 2026 Is the job funded
-
. The 12 PhD vacancies will be based across seven different universities in Europe: four in Denmark (three at the Technical University of Denmark and one at the University of Copenhagen), two in Germany
-
From patience to peril: how do C. difficile spores decide when it's safe to germinate? School of Mathematical and Physical Sciences PhD Research Project Self Funded Dr William Durham, Dr Robert
-
Novel routes for in-situ measurements during the manufacture of thin flexible electronic films. School of Chemical, Materials and Biological Engineering PhD Research Project Self Funded Prof
-
engineering Engineering » Other Physics » Electromagnetism Physics » Applied physics Physics » Other Researcher Profile First Stage Researcher (R1) Positions PhD Positions Application Deadline 24 May 2026 - 23
-
posts are designed for career development, and the successful candidate will undertake a PhD in parallel with their teaching and research support.You will be part of a large, vibrant, highly collaborative
-
Application deadline: 31/01/2026 Research theme: Control Engineering, Robotics UK only This 3.5-year PhD studentship is open to Home (UK) applicants. The successful candidate will receive an annual
-
outcomes. This PhD will deliver an original, staged programme of research evaluating the impact of routine medication exposure on immunotherapy outcomes. Melanoma will serve as the initial focus, with